RIVM would like to explore possibilities to eliminate obstacles during innovation of green chemistry with industry.

EU project EuroMix (European Test and Risk Assessment Strategies for Mixtures) was launched recently.

Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.

The number of medical examinations in which children are exposed to relatively high radiation doses has increased significantly over the last years.

We can all help to reduce pollution of the environment by pharmaceutical residues.

Bernice Notenboom’s Arctic March expedition team has reached the summit of Greenland. She has conquered the 3500-metre high summit on Greenland with functioning air measuring equipment.

Dr Hoang Hirschberg, employed at RIVM, has carried out PhD research into three alternatives for needle injections. She concluded that all alternatives have advantages and limitations.

Commissioned by the Dutch Health Care Inspectorate (IGZ), RIVM investigated whether excess adhesive is present in two types of injection needles from the Terumo Company (K-Pack II and Neolus).

Patients are increasingly being treated with complex medical technologies in their own home. This offers great benefits, however, it also introduces risks.

Climate reporter and expedition leader Bernice Notenboom and her team left for Greenland on 4 May 2015 for the second part of the Arctic March.